Zobrazeno 1 - 10
of 731
pro vyhledávání: '"Prokinetic agent"'
Publikováno v:
Applied Sciences, Vol 12, Iss 9, p 4175 (2022)
Jakyakgamcho-tang (JYGCT) has been used to treat various diseases. The interstitial cells of Cajal (ICC) regulate gastrointestinal (GI) motility as pacemaker cells. Here, we examined the effects of JYGCT on the pacemaker potential of the ICC in the s
Externí odkaz:
https://doaj.org/article/0ccdef0b59ea43b1a4f6effe707e0f9a
Publikováno v:
Drugs & Therapy Perspectives. 37:581-589
Metoclopramide is a prokinetic agent used to promote gastrointestinal motility. It is available for intramuscular, intravenous, subcutaneous and oral administration. In June 2020, metoclopramide nasal spray (MNS) 15 mg (administered 30 min before eac
Publikováno v:
Clinical and Experimental Gastroenterology, Vol Volume 14, Pp 413-428 (2021)
Clinical and Experimental Gastroenterology
Clinical and Experimental Gastroenterology
Gabrio Bassotti,1 Paolo Usai Satta,2 Massimo Bellini3 1Gastroenterology & Hepatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 2Gastrointestinal Unit, “G. Brotzu” Hospital, Cagliari, Italy; 3Gastrointesti
Autor:
Himanshu Pankhaniya, Darshit Ram
Publikováno v:
International Journal of Pharmacy and Pharmaceutical Sciences. :56-62
Objective: Cisapride is a novel prokinetic agent is best candidate for GERD. Cisapride 20 mg can be given thrice in a day given along with Proton pump inhibitor. By developing the sustain release formulation of Cisapride, the frequency of both drug c
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 5, Iss 4, Pp 300-309 (2015)
Chronic constipation is a common gastrointestinal disease severely affecting the patient׳s quality of life. The traditional treatment of constipation is the use of laxatives. Recently, several new drugs including lubiprostone, linaclotide and prucal
Externí odkaz:
https://doaj.org/article/1bb3d07b3a2249fe934ba0dfb941dc50
Publikováno v:
Терапевтический архив, Vol 86, Iss 8, Pp 35-41 (2014)
AIM. To evaluate the efficacy and safety of itopride used to treat the symptoms of functional dyspepsia (FD) of the upper gastrointestinal tract. MATERIALS AND METHODS. A prospective, open-label, multicenter trial using as a control the placebo respo
Externí odkaz:
https://doaj.org/article/ca1870f4a2fd43a4a9325ef66effe928
Publikováno v:
Expert Review of Endocrinology & Metabolism. 16:25-35
Introduction: Gastroparesis (GP) is characterized by delayed gastric emptying in the absence of mechanical obstruction. About 75% of GP patients are females. Diabetes and idiopathic are the two com...
Autor:
xinyong mao, Song Guo, Li-Wei Hou, Hong-Cai Wang, Shaoyuan Li, Tao Zhang, Peijing Rong, Juan Han
Publikováno v:
World Journal of Acupuncture - Moxibustion. 31:44-51
Objective To review systematically the therapeutic effect and safety of acupuncture or electroacupuncture (EA) on functional dyspepsia (FD). Methods Using computer, the randomized controlled trials (RCTs) of FD treated with acupuncture or EA were ret
Autor:
Alia Chisty
Publikováno v:
Medical Clinics of North America. 105:19-30
Dyspepsia affects a large percentage of the general population and can lead to lost work productivity and reduced quality of life. Patients with dyspepsia younger than 60 should not routinely undergo endoscopy but instead should pursue Helicobacter p
Publikováno v:
Gut
Gastroparesis is defined by delayed gastric emptying (GE) and symptoms of nausea, vomiting, bloating, postprandial fullness, early satiety and abdominal pain. Most common aetiologies include diabetes, postsurgical and postinfectious, but in many case